U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07937709) titled 'CAROTID STABILISE Pilot: Alirocumab for Symptomatic Carotid Stenosis' on Nov. 09.
Brief Summary: CAROTID STABILISE Pilot tested whether adding alirocumab to high-intensity atorvastatin changes high-risk plaque features in people recently affected by a stroke or transient ischemic attack (TIA) related to carotid artery narrowing. Forty adults aged 40-80 years were randomly assigned in equal groups to alirocumab 150 mg injected under the skin every two weeks or matching placebo every two weeks; both groups took atorvastatin 80 mg daily for 26 weeks. The main outcome was change from baseline to week 26 in intraplaque haemorrhage (IPH) ...